marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 03-03-2025
Syndax Pharmaceuticals Financial Ratios 2011-2025 | SNDX
Annual Financial Ratios Syndax Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.2 | -8.2 | -10.4 | 32.6 | -13.8 | -3.6 | -1.9 | -3.9 | -2.5 | - | - | - | - | - |
P/S |
56.5 | - | - | 5.8 | 664.7 | 133.9 | 91.3 | 111.8 | 89.8 | - | - | - | - | - |
EPS |
-3.7 | -3.0 | -2.5 | 0.5 | -1.9 | -1.8 | -2.9 | -2.9 | -3.2 | -1519.3 | -453.0 | - | - | - |
EV (Enterprise Value) |
1.62 B | 1.48 B | 1.51 B | 631 M | 942 M | 210 M | 136 M | 233 M | 111 M | 26 K | 8.52 M | 5.21 M | 30.8 M | - |
EBITDA per Share |
-3.87 | -3.1 | -1.95 | 1.33 | -1.73 | -1.88 | -2.99 | -2.95 | -2.99 | - | - | - | - | - |
EV/EBITDA |
22.9 | -11.6 | -3.1 | -1.4 | -3.2 | -2.0 | - | - | - | - | - | |||
PEG |
0.06 | 0.1 | 0.11 | -0.73 | 0.41 | -0.1 | 2.72 | -0.39 | 0.06 | - | - | - | - | - |
P/B |
4.6 | 3.1 | 3.3 | 2.0 | 4.0 | 6.4 | 2.6 | 2.3 | 1.3 | - | - | - | - | - |
P/CF |
-4.9 | -10.7 | -11.6 | 27.9 | -14.2 | -4.0 | -2.0 | -5.0 | -3.1 | - | - | - | - | - |
ROE % |
-110.63 | -37.78 | -31.95 | 6.10 | -29.01 | -177.36 | -139.43 | -58.28 | -52.86 | - | - | - | - | - |
ROA % |
-43.98 | -34.16 | -30.03 | 5.54 | -24.34 | -88.23 | -88.11 | -44.32 | -40.80 | - | - | - | - | - |
ROCE % |
-54.67 | -41.45 | -32.41 | 6.11 | -25.35 | -127.42 | -111.86 | -51.04 | -44.37 | - | - | - | - | - |
Current Ratio |
1.7 | 10.4 | 16.7 | 10.9 | 6.2 | 3.4 | 5.2 | 8.4 | 10.5 | - | - | - | - | - |
DSO |
58.6 | - | - | - | - | 27.9 | 60.9 | 65.3 | 91.5 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
58.6 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
58.6 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Syndax Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.98 | -0.8 | -0.85 | - | -0.73 | -0.64 | -0.59 | - | -0.58 | -0.62 | -0.63 | - | -0.4 | -0.44 | -0.54 | -0.44 | -0.46 | -0.42 | -0.56 | -0.44 | -0.41 | -0.47 | -0.53 | 0.7 | 0.68 | 0.74 | 0.79 | -0.8 | -0.84 | -0.47 | -2.85 | -0.59 | -0.84 | -0.47 | -2.85 | -105.57 | -790.85 | -440.52 | -206.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | -0.58 | -0.63 | -0.62 | - | -0.39 | -0.43 | -0.53 | -0.43 | -0.45 | -0.41 | -0.44 | -0.45 | -0.42 | -0.49 | -0.55 | -0.72 | -0.71 | -0.77 | -0.81 | -0.81 | -0.68 | -0.71 | -0.72 | -0.61 | -0.85 | -0.48 | -1.92 | -56.3 | -75.4 | -88.2 | -74.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-67.59 | -58.87 | -54.35 | -34.84 | -45.31 | -41.54 | -40.77 | -30.78 | -41.15 | -41.05 | -41.34 | -33.20 | -41.30 | -39.03 | -35.12 | -29.01 | -65.21 | -97.71 | -138.15 | -177.36 | -168.57 | -160.66 | -148.12 | -139.43 | -122.23 | -104.01 | -82.42 | -58.28 | -52.83 | -56.15 | -53.01 | -52.86 | -37.92 | -17.06 | -4.67 | 9.56 | 7.47 | 4.41 | 1.95 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-60.17 | -53.23 | -49.30 | -32.10 | -41.94 | -38.97 | -37.87 | -27.89 | -36.51 | -35.28 | -34.75 | -27.24 | -34.03 | -32.21 | -29.18 | -24.34 | -39.58 | -52.98 | -70.78 | -88.23 | -88.63 | -89.09 | -87.52 | -88.11 | -79.60 | -69.94 | -57.98 | -44.32 | -40.32 | -43.05 | -40.77 | -40.80 | -36.73 | -31.60 | -30.84 | -26.83 | -20.97 | -12.37 | -5.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-73.33 | -64.54 | -59.84 | -38.59 | -48.96 | -43.67 | -41.34 | -29.83 | -39.33 | -38.46 | -37.77 | -29.50 | -36.55 | -34.10 | -30.64 | -25.35 | -49.76 | -71.83 | -99.98 | -127.42 | -124.46 | -121.65 | -115.54 | -111.86 | -99.41 | -85.83 | -69.30 | -51.04 | -46.28 | -49.00 | -46.35 | -44.37 | -31.07 | -13.12 | -2.00 | 8.76 | 6.77 | 4.26 | 1.89 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
7.2 | 11.2 | 10.6 | 10.4 | 10.0 | 13.8 | 18.9 | 16.7 | 16.7 | 9.1 | 8.9 | 10.9 | 5.9 | 5.4 | 5.4 | 6.2 | 6.2 | 6.2 | 6.2 | 2.0 | 2.0 | 2.0 | 2.0 | 2.7 | 2.7 | 2.7 | 2.7 | 4.2 | 4.2 | 4.2 | 4.2 | 4.4 | 4.4 | 4.4 | 4.4 | 3.9 | 3.9 | 3.9 | 3.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency